Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Chataway

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
JAMA Neurology|May 5, 2020
Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in EnglandRaffaele Palladino, Ruth Ann Marrie, Azeem Majeed, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2016
Dimethyl fumarate may still have a role in progressive multiple sclerosisDomenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Neurology|September 2, 2021
Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort StudyRaffaele Palladino, Jeremy Chataway, Azeem Majeed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 8, 2023
Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based studyRaffaele Palladino, Ruth Ann Marrie, Azeem Majeed, et al.
Vascular Health and Risk Management|October 24, 2012
The potential benefit of stem cell therapy after stroke: an updateSoma Banerjee, Deborah A Williamson, Nagy Habib, et al.
Brain : a Journal of Neurology|August 7, 2024
An alternative therapeutic approach to haematopoetic stem cell transplantation in early cerebral adrenoleukodystrophyJeremy Chataway, Charles Wade, Elaine Murphy, et al.
CNS Drugs|May 12, 2016
Secondary Progressive Multiple Sclerosis: Definition and MeasurementDomenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2019
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosisNevin John, Antonia Carroll, Wallace J Brownlee, et al.
Practical Neurology|June 3, 2016
Clinicopathological case: rapid cognitive decline in an older manShona Scott, Jeremy Chataway, Jon Stone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 5, 2020
Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping reviewSarah Alexander, Guy Peryer, Emma Gray, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
JAMA Neurology|May 5, 2020
Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in EnglandRaffaele Palladino, Ruth Ann Marrie, Azeem Majeed, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2016
Dimethyl fumarate may still have a role in progressive multiple sclerosisDomenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Neurology|September 2, 2021
Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort StudyRaffaele Palladino, Jeremy Chataway, Azeem Majeed, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 8, 2023
Management of vascular risk in people with multiple sclerosis at the time of diagnosis in England: A population-based studyRaffaele Palladino, Ruth Ann Marrie, Azeem Majeed, et al.
Vascular Health and Risk Management|October 24, 2012
The potential benefit of stem cell therapy after stroke: an updateSoma Banerjee, Deborah A Williamson, Nagy Habib, et al.
Brain : a Journal of Neurology|August 7, 2024
An alternative therapeutic approach to haematopoetic stem cell transplantation in early cerebral adrenoleukodystrophyJeremy Chataway, Charles Wade, Elaine Murphy, et al.
CNS Drugs|May 12, 2016
Secondary Progressive Multiple Sclerosis: Definition and MeasurementDomenico Plantone, Floriana De Angelis, Anisha Doshi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2019
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosisNevin John, Antonia Carroll, Wallace J Brownlee, et al.
Practical Neurology|June 3, 2016
Clinicopathological case: rapid cognitive decline in an older manShona Scott, Jeremy Chataway, Jon Stone, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 5, 2020
Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping reviewSarah Alexander, Guy Peryer, Emma Gray, et al.
Pageof 19